Foseco India Ltd
Foseco India Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 investor presentation: what the company reported on revenue, margins and projects.
Based on Foseco India Ltd's Q1 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.
The short version
Q2 CY26 Revenue: INR 231.4 Cr (Page 9) - H1 CY26 Revenue: INR 433.3 Cr, up 41.7% YoY (Page 9) - H1 CY25 Revenue: INR 305.8 Cr (Page 9) - Q1 CY26 Revenue: INR 201.9 Cr (Page 9) - CY25 Revenue: INR 643.4 Cr, 22.6% growth over CY24 (Page 9) - The presentation does not provide explicit quarterly volume figures or detailed future revenue/volume targets. Quarterly EBITDA (Q2 CY26): INR 58.3 Cr, with a margin of 25.2% (Page 9) - Year-on-Year EBITDA Growth: Up from INR 49.7 Cr and 14.6% margin in Q2 CY25 to 58.3 Cr and 25.2% margin in Q2 CY26 (i
From Foseco India Ltd's Q1 FY27 earnings-call transcript · updated 25 Sept 2026.
Revenue & Sales Performance
- Q2 CY26 Revenue: INR 231.4 Cr (Page 9)
- H1 CY26 Revenue: INR 433.3 Cr, up 41.7% YoY (Page 9)
- H1 CY25 Revenue: INR 305.8 Cr (Page 9)
- Q1 CY26 Revenue: INR 201.9 Cr (Page 9)
- CY25 Revenue: INR 643.4 Cr, 22.6% growth over CY24 (Page 9)
- The presentation does not provide explicit quarterly volume figures or detailed future revenue/volume targets.
2 more points management made on revenue & sales performance
Profitability & Margins
See what Foseco India Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Acquisition of Mehsana (Gujarat) manufacturing facility from Vesuvius India Limited by slump sale; INR 43.25 Cr lump sum cash consideration; expected completion by 31 December 2026; requires GIDC approval and other regulatory clearances (Page 21).
- Acquisition of 75% stake in Morganite Crucible India Limited, renamed Foseco Crucible India Limited; no direct capex stated; equity issued as consideration; completed by June 2026 (Page 20).
- Mention of focused capex to strengthen operational excellence, aiming for faster turnaround, reliable fulfillment, lower cost to serve (Page 23).
2 more points management made on capital expenditure plans
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Foseco India Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points management made on order book & pipeline
Foseco India Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹202 Cr, net profit ₹33 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Foseco India Ltd's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Prasol Chemicals Ltd (Q1 FY27)
Q1 FY27 Revenue from Operations: ₹433.6 crores . Key investor presentation takeaways from Prasol Chemicals Ltd's Q1 FY27 investor presentation — and how it rank
- Vipul Organics Ltd (Q1 FY27)
Q1 FY27 net revenue: ₹51.78 crore, up +37.7% YoY (Page 13) . Key concall takeaways from Vipul Organics's Q1 FY27 earnings call — and how it ranks against…
- Fine Organic Industries Ltd (Q1 FY27)
Revenue from Operations (Consolidated) for Q1FY27: Rs 694.2 Cr, up 18.0% YoY from Rs 588.4 Cr in Q1FY26 (Page 34). Key concall takeaways from Fine Organic…
- Chemfab Alkalis Ltd (Q1 FY27)
Consolidated Q1FY27 Revenue from Operations:** ₹73.16 crore, down 20.08% YoY (from ₹91.54 crore in Q1FY26). Key concall takeaways from Chemfab Alkalis Ltd's Q1…
Frequently Asked Questions
What were Foseco India Ltd Q1 FY27 results?
Q2 CY26 Revenue: INR 231.4 Cr (Page 9) - H1 CY26 Revenue: INR 433.3 Cr, up 41.7% YoY (Page 9) - H1 CY25 Revenue: INR 305.8 Cr (Page 9) - Q1 CY26 Revenue: INR 201.9 Cr (Page 9) - CY25 Revenue: INR 643.4 Cr, 22.6% growth over CY24 (Page 9) - The presentation does not provide explicit quarterly volume figures or detailed future revenue/volume targets. Quarterly EBITDA (Q2 CY26): INR 58.3 Cr, with a margin of 25.2% (Page 9) - Year-on-Year EBITDA Growth: Up from INR 49.7 Cr and 14.6% margin in Q2 CY25 to 58.3 Cr and 25.2% margin in Q2 CY26 (i
What is Foseco India Ltd share price analysis?
Foseco India Ltd currently shows a neutral. The stock trades at a P/E of 48.3 with a market cap of ₹5,033 Cr. Investors should review the full earnings analysis for detailed insights.
Is Foseco India Ltd planning capital expenditure?
Acquisition of Mehsana (Gujarat) manufacturing facility from Vesuvius India Limited by slump sale; INR 43.25 Cr lump sum cash consideration; expected completion by 31 December 2026; requires GIDC approval and other regulatory clearances (Page 21).
Keep Foseco India Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.